Literature DB >> 32265077

Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative.

Anees Daud1, Mandeep R Mehra2, Alfonso Siu1, Maryl R Johnson3, Michael Perch4, Marie Budev5, Yousef Zakharia6, Richard Cheng7, Jose Nativi-Nicolau1, Josef Stehlik8.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32265077     DOI： 10.1016/j.healun.2020.02.015

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  3 in total

1.  Immune Checkpoints Expression in Chronic Lung Allograft Rejection.

Authors:  Ilaria Righi; Valentina Vaira; Letizia Corinna Morlacchi; Giorgio Alberto Croci; Valeria Rossetti; Francesco Blasi; Stefano Ferrero; Mario Nosotti; Lorenzo Rosso; Mario Clerici
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

Review 2.  Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?

Authors:  Umberto Maggiore; Alessandra Palmisano; Sebastiano Buti; Giulia Claire Giudice; Dario Cattaneo; Nicola Giuliani; Enrico Fiaccadori; Ilaria Gandolfini; Paolo Cravedi
Journal:  Transpl Int       Date:  2021-10-28       Impact factor: 3.842

Review 3.  Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates.

Authors:  Shun Kawashima; Kole Joachim; Maen Abdelrahim; Ala Abudayyeh; Kenar D Jhaveri; Naoka Murakami
Journal:  Korean J Transplant       Date:  2022-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.